Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arch Toxicol. 2019 Apr 23;93(6):1543–1553. doi: 10.1007/s00204-019-02446-1

Fig. 6.

Fig. 6

Representative blots of a immunoblot analysis of the amounts of HIF-1α in nuclear extracts from LV tissues and VEGF in protein extracts from homogenates of LV tissues of wild-type and Ahr−/− mice treated with Ang II and fenofibrate. b Capillary detected by immunohistochemical staining with anti-CD31 antibody in the LV wall. Scale bars, 100 μm. c Quantitative analysis of the capillary density in the left ventricle of wild-type and Ahr−/− mice treated with Ang II and fenofibrate. Data are mean ± SEM of six mice per group. *P < 0.05 vs. wild-type control mice; #P < 0.05 vs. wild-type Ang II mice; P < 0.05 vs. Ahr−/− Ang II mice